Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease

KANBAY, MEHMET; Wolf, Myles; Selçoki, Yusuf; Solak, Yalçın; İkizek, Mustafa; Uysal, Sema; Segall, Liviu; Armutçu, Ferah; Eryonucu, Beyhan; Goldsmith, David; Duranay, Murat; Covic, Adrian

doi:10.1007/s11255-011-0076-x

Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease

Atıf İçin Kopyala

KANBAY M. , Wolf M., Selçoki Y., Solak Y., İkizek M., Uysal S., ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.44, ss.1169-1175, 2012 (SCI İndekslerine Giren Dergi)

Cilt numarası: 44 Konu: 4
Basım Tarihi: 2012
Doi Numarası: 10.1007/s11255-011-0076-x
Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
Sayfa Sayıları: ss.1169-1175

Özet

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). Recent data implicate disordered bone and mineral metabolism, including changes in serum levels of calcium, phosphate, parathyroid hormone (PTH), vitamin D, fibroblast growth factor-23 (FGF-23), and fetuin A, as novel risk factors for arterial calcification. The potential role of calcitonin, another hormonal regulator of mineral and bone metabolism, has not been studied in detail.